Western blotting
24 hours and 10 times concentrated conditioned media, 1.5 mol/L NaCl washes and cell lysates from mock and gremlin-overexpressing VEGF -/-fibroblasts were probed with anti-gremlin antibody (R&D System) in a Western blot.
Confluent HUVECs were detached from culture plates, resuspended in M199 medium containing 5% FCS, allowed to adhere on immobilized gremlin or FG for the indicated time in the absence or in the presence of 10 µg/mL of BV4 antibody (Immunological Sciences, Rome, Italy). Cells were then lysed in lysis buffer [50 mmol/L Tris-HCl buffer (pH 7.4) containing 150 mmol/L NaCl, 1% Triton X-100, 1 mmol/L Na 3 VO 4 , and protease and phosphatase inhibitors (Sigma)]. Next, 50 µg of total cell lysate were separated by SDS-PAGE and probed with anti-phospho-VEGFR2 antibody (pTyr1175, Cell Signaling Technology, Beverly, MA), anti-FAK antibody (Santa Cruz Biotechnology), anti-VEGFR2 antibody (Santa Cruz Biotechnology) or anti-phospho-β 3 integrin (pTyr759, Santa Cruz Biotechnology) in a Western blot.
Boyden chamber haptotactic assay
Mock and gremlin-overexpressing VEGF -/-fibroblasts were seeded on the lower face of gelatin-coated PVP-free polycarbonate filters (8 µm pore size, Costar, Cambridge, MA). Filters were incubated for 48 hours in DMEM 10% FCS to allow attached cells to deposit their own ECM and inserted in the Boyden chamber. Then, ECD-VEGFR2-EYFP-overexpressing GM7373 cells were seeded in the upper compartment of the Boyden chamber at 1×10 6 cells/mL. After 1 hour of incubation at 37°C, cells adherent to both sides of the filter were fixed and immunostained for β 3 integrin as described below. Then, cells were analysed using a LSM510 Meta confocal microscope equipped with Plan-Apochromat 63x/1.4 NA oil objective (Carl Zeiss). Z-Stack sections and orthogonal z reconstitution for VEGFR2 were analysed by confocal microscopy, while 3D reconstruction images were obtained through AxioVision Inside 4D module (Carl Zeiss).
Immobilization of proteins to tissue culture plastic or glass coverslip
Aliquots (100 µL) of sterile PBS containing 2 µg/mL of gremlin or FG were added to polystyrene tissue culture plates or glass coverslips. After 16 hours of incubation at 4°C, the solution was removed and wells were washed 3 times with cold PBS. Uncovered plastic/glass was blocked with 1 mg/mL bovine serum albumin (BSA) for 1 hour at room temperature. Under these conditions gremlin binds to tissue culture plastic in a dose-dependent manner, with maximal binding at coating concentrations ≥ 2 µg/mL, as assessed by ELISA. Also, substratum-immobilized gremlin is resistant to high molar salt (2 mol/L NaCl) and detergent (0.2% Triton X-100) washes ( Figure S3 ).
Immobilized gremlin ELISA
Ninety-six-well tissue culture plates were coated for 16 hours at 4°C with 0.2, 2 or 10 µg/mL of gremlin as described above. Then, plastic-immobilized gremlin was washed with 2 mol/L NaCl or with 0.2% Triton X-100 for 15 minutes at 37°C. An anti-gremlin goat polyclonal antibody (R&D Systems) diluted in PBS containing 0.1% BSA, 5 mmol/L EDTA, 0.004% Tween 20 (PBET buffer) was added to the wells at 500 ng/mL and incubated for 2 hours at room temperature. Finally, wells were incubated for 1 hour at room temperature with a secondary anti-goat horseradish peroxidase (HRP)-conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Ventral plasma membrane (VPM) preparation
VPMs were prepared by osmotic shock using a modification of the squirting lysis technique 8 . Briefly, cells were washed twice with ice-cold water; after 1 minute cells were squirted over by using a jet of ice-cold water and immediately fixed for immunocytochemistry analysis. In all the experiments, the absence of DAPI staining and the persistence of actin filaments were used to unequivocally identify the VPM remnants bound to the substratum.
Glass coverslips were coated with gremlin, FG or FGF2 (2 µg/mL) as described above. Mock cells (75.000/cm 2 in cell culture medium containing 1% FCS) or cells expressing FRNK and FRNKL1034S mutant and were allowed to adhere to the coverslips for 4 hours in absence or presence of different inhibitors used in pre-treatment or not: VEGFR2 inhibitor SU5416 (5 µmol/L, Calbiochem, La Jolla, CA), RhoA inhibitor exoenzyme C3 from Clostridium botulinum (1 µg/mL, Calbiochem), β 3 integrin inhibitor BV4 monoclonal antibody (10 µg/mL, Immunological Sciences). For lipid rafts disruption experiments, cells were incubated in suspension (1 hour at 37°C) with 2,6-di-O-methyl-β-ciclodextrin (MβCD, 10 mmol/L, Sigma). VPMs were acquired under an Axiovert 200 fluorescence microscope equipped with a Plan-Apochromat 63x/1.4 NA oil objective and ApoTome system (Carl Zeiss). VEGFR2-positive areas and total VPM areas, defined by actin staining, were quantified using Image-Pro Plus software.
Time-lapse adhesion assay
β 3 -ECFP and ECD-VEGFR2-EYFP co-expressing GM7373 cells were seeded and cultured on coverslips for 24 hours in FCS-free Endothelial Cell Basal Medium (Lonza, Basel, Swiss). Coverslips were then flipped on immobilized gremlin or FG coated µslides (IBIDI). Z-stack images in time-lapse were recorded for 120 minutes using a Zeiss Axiovert 200M epifluorescence microscope equipped with a Plan-Apochromat 63x/1.4 NA oil objective and ApoTome system. Collected images were then used to quantify the fluorescence of ECD-VEGFR2-EYFP and β 3 -ECFP normalized to the background.
Fluorescence resonance energy transfer (FRET) analysis
FRET experiments were performed as previously described 3 . Briefly, β 3 -ECFP/ECD-VEGFR2-EYFP GM7373 cells were seeded on immobilized gremlin or FG (both at 2 µg/mL) and allowed to adhere for 4 hours. After adhesion, VPMs were isolated, fixed with 4% paraformaldehyde and subjected to FRET analysis at LSM510 Meta confocal microscope (Carl Zeiss). To this purpose, a region of interest was selected and photobleached by applying 100% intensity of a 514 nm laser. FRET efficiency was calculated using the formula: FRET = (D post -D pre )/D post , where D post and D pre represent the donor (ECFP) emission intensities before and after photobleaching, respectively. FRET efficiency was also measured in a non-photobleached region of the same cell as an in situ control. In all experiments, cells transfected with ECFP-EYFP fusion protein were used as FRET positive controls 9 .
Cell motility assay and lipid raft disruption experiments EC motility was assessed by time-lapse video-microscopy. To this purpose, ECs were seeded on immobilized gremlin or FG (both at 2 µg/mL) at 150 cells per mm 2 in 24 well plates in the absence or in the presence of SU5416 (5µmol/L, Calbiochem), BV4 antibody (10 µg/mL, Immunological Sciences) or exoenzyme C3 (1 µg/mL, Calbiochem). For lipid rafts disruption experiments, cells were incubated in suspension (1 hour at 37°C) with MβCD (10 mM, Sigma) followed by 1 hour incubation with cholesterol (chol, 400 mg/mL, Sigma). Constant temperature (37°C) and 5% CO 2 were maintained throughout the experimental period by means of a heatable stage and climate chamber. Cells were observed under an inverted photomicroscope (Zeiss Axiovert 200M) and phase-contrast snap photographs (one every 10 minutes) were digitally recorded for 8 hours. Cell paths (40-50 cells per experimental point) were generated from centroid positions and migration parameters were analysed with the "Chemotaxis and Migration Tool" of ImageJ Software (http://rsbweb.nih.gov/ij).
Immunocytochemistry
Fixed whole cells or VPMs were permeabilized with 0.5% Triton-X100 and saturated with 3% BSA in PBS. Adherent cells, migrating cells or VPMs underwent the following staining procedures: i) actin staining: samples were incubated for 30 minutes with TRITC-phalloidin (0.9 mg/mL in PBS, Sigma); ii) GM1 ganglioside staining: samples were incubated for 30 minutes with AlexaFluor 594-conjugated Cholera Toxin B subunit (CTB, Sigma); iii) paxillin immunostaining: samples were incubated overnight with a monoclonal anti-paxillin antibody (Transduction Laboratories, Lexington, KY) followed by a 45 minutes incubation with AlexaFluor 488-conjugated anti-mouse IgG (Molecular Probes, Life Technologies); iv) total VEGFR2 immunostaining: samples were incubated overnight with a rabbit polyclonal anti-VEGFR2 antibody (Santa Cruz Biotechnology) followed by 1 hour incubation with AlexaFluor 594 and AlexaFluor 488-conjugated anti-rabbit IgG or with a goat polyclonal anti-VEGFR2 antibody (Santa Cruz Biotechnology) followed by 1 hour incubation with
